Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
Public ClinicalTrials.gov record NCT02600429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy: SEER-1
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the safety and efficacy of RGN-259 Ophthalmic Solution compared to placebo for the treatment of NK.
Study identification
- NCT ID
- NCT02600429
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2015 (Actual)
- Primary completion
- Nov 20, 2019 (Actual)
- Completion
- Mar 9, 2020 (Actual)
- Last update posted
- Aug 30, 2023
2015 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hull Eye Center | Lancaster | California | 93534 | — |
| Vision Institute | Colorado Springs | Colorado | 80907 | — |
| Eye Center of Northern Colorado | Fort Collins | Colorado | 80525 | — |
| Insight Vision Group | Parker | Colorado | 80134 | — |
| Medical Faculty Associates, Inc. | Washington D.C. | District of Columbia | 20037 | — |
| Midwest Cornea Associates, LLC | Indianapolis | Indiana | 46290 | — |
| Koffler Vision Group | Lexington | Kentucky | 40509 | — |
| Richard Eiferman, MD, PSC | Louisville | Kentucky | 40205 | — |
| The Eye Care Institute | Louisville | Kentucky | 40206 | — |
| Central Maine Eye Care | Lewiston | Maine | 04240 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02600429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02600429 live on ClinicalTrials.gov.